查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999253

血液透析和腹膜透析市场：按治疗类型、方法、技术、产品类型、患者类型和最终用户划分－2026年至2032年全球市场预测

Hemodialysis & Peritoneal Dialysis Market by Treatment Type, Modality, Technology, Product Type, Patient Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血液透析和腹膜透析市场价值将达到 959.1 亿美元，到 2026 年将成长至 1,025 亿美元，到 2032 年将达到 1,617.3 亿美元，复合年增长率为 7.74%。

主要市场统计数据
基准年 2025 959.1亿美元
预计年份：2026年 1025亿美元
预测年份 2032 1617.3亿美元
复合年增长率 (%) 7.74%

简要概述正在重塑透析护理服务体系和相关人员优先事项的临床、技术和营运趋势。

由于技术进步、护理模式的转变、人口压力以及监管改革，肾衰竭治疗格局正在发生显着变化。儘管血液透析在许多医疗系统中仍然是肾臟替代疗法的基石，但腹膜透析因其以患者为中心的优势（例如患者自主性和减轻医疗机构负担）而重新受到关注。设备自动化、透析液配方和血管通路管理的进步不断改善临床实务。同时，基于价值的支付模式和居家照护奖励正在重塑医疗服务提供者的奖励机制。

居家照护策略、先进设备的引入以及对永续性的需求如何共同作用，重塑护理服务模式、供应商优先事项和支付方奖励。

在透析领域，变革正在发生，这些变革影响着临床路径、护理服务地点和供应商生态系统。居家照护的日益普及是其中最显着的变化之一，这得益于设备人体工学的改进、远端患者监护以及系统的看护者培训计画。这种居家照护的转变正在改变使用模式，催生对小型化、易用型设备的需求，并重新定义以远端支援和物流为重点的服务模式。

对 2025 年实施的费用修订如何重组整个透析价值链的采购、筹资策略和产品设计进行全面评估。

美国2025年实施的关税制度正在影响整个透析价值链的采购决策、供应商网络和成本结构。进口关税和基于关税的监管调整使得筹资策略备受关注，迫使医疗服务提供者和製造商实现供应商多元化、采用近岸生产模式，并重新评估其库存管理政策。这些变化对透析机、监控系统和管路组件等零件密集型产品类型的影响尤其显着，而国际供应链历来在这些产品类别中扮演核心角色。

基于精确细分的智能，将临床模式、产品特性、终端用户管道和患者群体与优化目标定位的策略要求连结起来。

细分市场层面的洞察揭示了不同治疗类型、模式、技术、产品类型、最终用户和患者群体之间的不同趋势，指南有针对性的策略方法。基于治疗类型，血液透析和腹膜透析之间的比较趋势凸显了营运规模和患者体验的差异。在腹膜透析领域，自动化腹膜透析和连续移动腹膜透析之间的模式差异会影响设备的复杂性、培训强度以及远端监测的需求。基于模式，居家照护和机构照护之间的差异决定了从资金分配到人员配备模式的方方面面，其中居家照护类别进一步细分为「辅助照护」和「自我护理」路径，每种路径都有不同的临床管治和报销规定。

在全球范围内，区域医疗保健系统、报销机制和供应链现状如何影响不同的市场进入路径和市场进入优先事项？

区域趋势持续对整体透析护理领域的技术应用、报销机制和营运模式产生决定性影响。在美洲，整合的医疗保健系统、成熟的透析服务提供者网路以及强调以价值为导向的医疗政策，推动了对可扩展的院内效率提升工具的需求，同时也提高了人们对能够减轻医疗机构负担的居家透析模式的兴趣。相较之下，欧洲、中东和非洲地区不同的报销环境和法规结构则影响先进技术的应用速度。一些地区，尤其是那些优先考虑慢性病管理和远距医疗基础设施的市场，正在经历快速的技术应用。

竞争对手的行动和策略性投资表明，我们正在向一体化产品和服务平台、临床证据的创造以及区域业务基础的扩张做出明确转变。

透析生态系统中的主要企业正致力于透过临床差异化、平台整合和服务型模式相结合的方式来维持成长并保障利润率。产品创新重点在于更小巧、更直觉的家用透析设备、能够提升生物相容性和清除率的先进透析器材料，以及支援远距治疗调整和早期疗育的整合式监测系统。此外，各公司还将培训项目、物流管理以及与医疗服务提供者基于疗效的伙伴关係纳入其服务组合，这反映了他们对永续价值的认识：永续价值往往在于设备性能与持续临床支援之间的相互作用。

为製造商、医疗保健提供者、保险公司和供应链领导者提供可操作的策略重点，以增强韧性并加速治疗方法的转变。

行业领导者应优先采取一系列有针对性的倡议，以克服当前面临的挑战，并在透析护理的各个领域抓住新的机会。製造商应加快模组化设计的研发，以减少对价格敏感型组件的依赖，简化现场维护，同时增强数位遥测功能，以支援远端监测和预测性维护。医疗服务提供者应透过严格的培训课程、完善的看护者支援系统以及基于伙伴关係的照护路径，扩大居家照护计画的覆盖范围，从而降低病患就医的门槛。保险公司和政策制定者可以透过评估治疗效果并调整报销政策，促进可扩展的居家照护服务，从而对居家照护的普及产生重要影响。

透明地整合第二手资料、有针对性的一手访谈和严格的资料三角验证，以确保获得可靠且可操作的见解。

本报告的研究结合了系统性的二手文献综述和结构化的原始研究，以确保结论的平衡性和检验。二手研究阶段纳入了同行评审的临床文献、监管申报文件、医疗设备技术规范和政策文件，以建立对临床实践和技术性能的基础性理解。为了进一步巩固这一基础，我们对包括临床医生、采购经理、医疗设备工程师和支付方在内的众多相关人员进行了访谈，检验趋势、掌握实际情况并识别新兴的商业性趋势。

临床、技术和商业性讯号的明确整合，突显了实现永续成长和改​​善患者预后的明确路径。

透析产业正处于一个转折点，其特点是技术创新融合、医疗服务模式转型以及营运复杂性日益增加。在小型化设备和远端监控的推动下，居家照护正成为许多患者替代机构照护的理想选择，而先进的治疗方法和材料也在提升特定患者群体的临床治疗能力。同时，政策变化和收费系统调整正在重塑采购和生产的优先事项，迫使相关人员采取更具韧性和灵活性的策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依治疗方法分類的血液透析和腹膜透析市场

  • 血液透析
  • 腹膜透析
    • 自动腹膜透析
    • 持续性携带式腹膜透析

第九章 血液透析及腹膜透析市场：依透析方式划分

  • 在家工作
    • 辅助型
    • 自我管理
  • 设施内部

第十章 血液透析及腹膜透析市场：依技术划分

  • 传统血液透析
  • 线上血液透析过滤
    • 混合流
    • 置换流

第十一章 血液透析与腹膜透析市场：依产品类型划分

  • 浓缩液
  • 透析机
  • 透析器
    • 高通量
    • 低通量
  • 监控系统
  • 管组

第十二章 依病患类型分類的血液透析和腹膜透析市场

  • 成人版
  • 老年人
  • 儿童

第十三章 血液透析和腹膜透析市场：依最终用户划分

  • 透析中心
  • 居家照护设施
  • 医院
  • 专科诊所

第十四章 血液透析及腹膜透析市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 血液透析与腹膜透析市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 血液透析和腹膜透析市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国血液透析与腹膜透析市场

第十八章：中国血液透析及腹膜透析市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DaVita Inc.
  • Diaverum AB
  • Fresenius Medical Care AG & Co. KGaA
  • Jafron Biomedical Co., Ltd.
  • Medica SpA
  • Medtronic plc
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Rockwell Medical, Inc.
  • Toray Industries, Inc.
Product Code: MRR-8201ABF21C57

The Hemodialysis & Peritoneal Dialysis Market was valued at USD 95.91 billion in 2025 and is projected to grow to USD 102.50 billion in 2026, with a CAGR of 7.74%, reaching USD 161.73 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 95.91 billion
Estimated Year [2026] USD 102.50 billion
Forecast Year [2032] USD 161.73 billion
CAGR (%) 7.74%

A concise orientation to the evolving clinical, technological, and operational forces reshaping dialysis care delivery and stakeholder priorities

The treatment landscape for kidney failure is undergoing a meaningful evolution driven by technology, shifting care models, demographic pressures, and regulatory recalibrations. Hemodialysis remains a cornerstone of renal replacement therapy delivery in many health systems, while peritoneal dialysis is gaining renewed attention because of patient-centric advantages such as autonomy and reduced facility burden. Advances in machine automation, fluid formulations, and vascular access management continue to refine clinical practice, even as value-based payment models and home-care incentives reshape provider incentives.

Clinicians and operators must balance acute clinical imperatives with long-term sustainability. This means integrating digital monitoring to personalize therapy, strengthening supply chain partnerships to mitigate disruption, and rethinking training programs to scale home-based modalities. At the same time, manufacturers are investing in modular platforms, improved dialyzer membranes, and monitoring systems that enhance efficiency, safety, and data connectivity. As a result, stakeholders across the continuum are retooling strategies to meet changing patient preferences, regulatory expectations, and competitive dynamics, while preserving high standards of clinical effectiveness and operational reliability.

How home-first strategies, advanced device adoption, and sustainability imperatives are jointly rewriting care delivery models, supplier priorities, and payer incentives

The dialysis landscape is experiencing transformative shifts that affect clinical pathways, care delivery locations, and supplier ecosystems. Increasing acceptance of home modalities is one of the most consequential changes, supported by improvements in device ergonomics, remote patient monitoring, and structured caregiver training programs. This migration toward home-based care alters utilization patterns, creates demand for compact, user-friendly devices, and redefines service models to emphasize remote support and logistics.

Another transformative trend is the selective adoption of advanced dialysis technologies such as online hemodiafiltration and more sophisticated dialysis machine telemetry. These innovations are introducing differentiated clinical outcomes for specific patient cohorts and prompting payers and providers to consider revised protocols and reimbursement models. Concurrently, there is intensified focus on sustainability and cost containment, encouraging adoption of low-waste concentrates, reusable components where clinically appropriate, and lifecycle procurement strategies. Collectively, these shifts are prompting manufacturers to accelerate product differentiation, providers to reconfigure care pathways, and policymakers to revisit regulations and incentives that influence where and how dialysis care is delivered.

An integrated assessment of how tariff changes enacted in 2025 have reshaped procurement, sourcing strategy, and product design across the dialysis value chain

The tariff landscape introduced in the United States in 2025 has influenced procurement decisions, supplier networks, and cost structures across the dialysis value chain. Import duties and tariff-driven regulatory adjustments have contributed to increased attention on sourcing strategies, prompting health systems and manufacturers to re-evaluate supplier diversification, nearshoring, and inventory management policies. These shifts have had particular resonance for component-heavy product categories such as dialysis machines, monitoring systems, and tubing sets where international supply streams historically play a central role.

As organizations adjust to elevated import costs and compliance complexity, many have accelerated efforts to localize key manufacturing steps, renegotiate long-term supplier agreements, and redesign product bill-of-materials to reduce tariff exposure. Providers have responded by reassessing capital procurement timing and by intensifying value-based contracting conversations that account for total cost of ownership, including logistics and tariff-related expenses. Simultaneously, innovation strategies have been influenced as companies target modular designs and alternative raw materials to limit tariff sensitivity. The cumulative effect is a reconfiguration of commercial playbooks and an increased premium on supply chain transparency and contractual resilience.

Precise segmentation-driven intelligence linking clinical modality, product characteristics, end-user channels, and patient cohorts to strategic imperatives for optimized targeting

Segment-level insights reveal differentiated dynamics across treatment type, modality, technology, product, end-user, and patient cohorts that inform targeted strategic approaches. Based on Treatment Type, the comparative trajectories of Hemodialysis and Peritoneal Dialysis highlight contrasting operational footprints and patient experience profiles; within Peritoneal Dialysis, the distinctions between Automated Peritoneal and Continuous Ambulatory Peritoneal modalities influence device complexity, training intensity, and remote-monitoring needs. Based on Modality, the home versus in-center divide frames everything from capital allocation to staffing models, with the Home category further differentiated by Assisted Care and Self Care pathways that carry distinct clinical governance and reimbursement implications.

Based on Technology, the split between Conventional Hemodialysis and Online Hemodiafiltration underscores differing clinical evidence bases and infrastructure requirements, while the latter's Mixed Flow and Substitution Flow variants create nuanced clinical and capital considerations for adoption. Based on Product Type, categories such as Concentrates Fluids, Dialysis Machines, Dialyzers, Monitoring Systems, and Tubing Sets each follow separate innovation and regulatory timelines, and within Dialyzers the High Flux and Low Flux subtypes carry implications for therapy customization and supply inventory planning. Based on End User, distribution and service models vary significantly among Dialysis Centers, Home Care Settings, Hospitals, and Specialty Clinics, shaping commercial channels and aftermarket services. Based on Patient Type, distinct clinical pathways and device configurations are required for Adult, Geriatric, and Pediatric populations, affecting training protocols, dosing algorithms, and caregiver supports. Taken together, these segmentation lenses permit granular prioritization of investments, tailored go-to-market tactics, and differentiated clinical support programs that align with both patient needs and organizational capabilities.

How regional healthcare structures, reimbursement diversity, and supply chain realities are shaping differentiated adoption paths and go-to-market priorities globally

Regional dynamics continue to exert a defining influence on technology adoption, reimbursement mechanisms, and operational models across dialysis care. In the Americas, health system consolidation, established dialysis provider networks, and policy emphasis on value-based care drive demand for scalable in-center efficiency tools and a growing interest in home dialysis models that reduce facility burden. In contrast, Europe, Middle East & Africa present a mosaic of reimbursement environments and regulatory frameworks that influence adoption cadence for advanced technologies, with pockets of rapid uptake in markets that prioritize chronic disease management and remote care infrastructure.

Asia-Pacific encompasses a range of healthcare maturity levels, from advanced systems investing in digital health and localized manufacturing to emerging markets where access, affordability, and workforce constraints limit rapid modality transitions. Across regions, supply chain strategies, tariff exposure, and local manufacturing incentives influence product availability and pricing dynamics. The practical implication is that manufacturers and providers must calibrate regional go-to-market strategies, regulatory engagement, and service delivery models to the specific reimbursement incentives, infrastructure readiness, and patient population characteristics of each geography.

Competitive behaviors and strategic investments reveal a clear pivot toward integrated product-service platforms, clinical evidence generation, and regional capability expansion

Leading companies in the dialysis ecosystem are pursuing a mix of clinical differentiation, platform consolidation, and service-based models to sustain growth and defend margins. Product innovation focuses on smaller, more intuitive home devices, advanced dialyzer materials that improve biocompatibility and clearance, and integrated monitoring systems that enable remote titration of therapy and earlier intervention. Companies are also expanding service portfolios to include training programs, logistics management, and outcomes-based partnerships with providers, reflecting recognition that durable value often lies in the interplay between device performance and continuous clinical support.

Strategic alliances and selective acquisitions remain active pathways to accelerate capability-building, particularly in digital health, disposables manufacturing, and regional distribution. Firms are investing in real-world evidence generation to support differentiated clinical claims and payer negotiations, while also optimizing aftermarket service and consumables revenue streams. The competitive landscape rewards organizations that can combine robust clinical data, regulatory agility, and operational excellence to deliver seamless patient journeys across in-center and home settings.

Actionable strategic priorities for manufacturers, providers, payers, and supply chain leaders to strengthen resilience and accelerate modality transitions

Industry leaders should prioritize a set of targeted actions to navigate current headwinds and capture emerging opportunities across the dialysis continuum. Manufacturers ought to accelerate modular design initiatives that reduce reliance on tariff-sensitive components and simplify field servicing, while simultaneously enhancing digital telemetry to support remote monitoring and predictive maintenance. Providers should expand home modality programs through rigorous training curriculums, caregiver support frameworks, and partnership-based care pathways that lower barriers to patient uptake. Payers and policymakers can meaningfully influence adoption by calibrating reimbursement policies to reward outcomes and enable scalable home care delivery.

Supply chain leaders should pursue supplier diversification and nearshoring where feasible to reduce exposure to tariff volatility and logistical bottlenecks, and should increase investments in inventory analytics to balance cost and clinical readiness. Commercial teams must refine value propositions that articulate total cost of care and clinical outcomes rather than focusing on unit price alone, thereby enabling longer-term contracting that absorbs short-term tariff fluctuations. Finally, all stakeholders should commit to robust data governance and interoperability standards to ensure patient safety, facilitate remote care, and accelerate evidence generation that supports appropriate therapy selection.

A transparent synthesis of secondary evidence, targeted primary interviews, and rigorous data triangulation to ensure credible and actionable insights

The research underpinning this report combines systematic secondary review with structured primary engagement to ensure balanced, verifiable insights. The secondary phase incorporated peer-reviewed clinical literature, regulatory filings, device technical specifications, and policy documents to establish a baseline understanding of clinical practice and technology performance. This foundation was augmented by primary interviews with a cross-section of stakeholders including clinicians, procurement leaders, device engineers, and payers to validate trends, capture operational realities, and surface emerging commercial behaviors.

Data triangulation techniques were applied to reconcile discrepancies between reported performance claims, regulatory documentation, and frontline user experiences. Segmentation frameworks were iteratively refined to reflect clinically meaningful distinctions across treatment type, modality, technology, product, end-user, and patient cohorts. Limitations are acknowledged with transparency: where evidence was sparse, findings were flagged as emergent and recommendations were framed to accommodate scenario-based planning. Ethical considerations guided respondent confidentiality and conflict-of-interest screening during primary engagement to preserve the integrity of conclusions.

A definitive synthesis of clinical, technological, and commercial signals that highlights decisive pathways to sustainable growth and improved patient outcomes

The dialysis sector stands at an inflection point characterized by converging technological innovation, shifting care delivery models, and heightened operational complexity. Home modalities, fueled by device miniaturization and remote monitoring, present a compelling alternative to facility-centric care for many patients, while advanced therapies and materials are refining clinical capabilities for selected cohorts. At the same time, policy changes and tariff dynamics are reshaping procurement and manufacturing priorities, compelling stakeholders to adopt more resilient, agile strategies.

Looking ahead, organizations that invest in integrated product-service offerings, strengthen regional supply chain resilience, and generate robust real-world evidence are positioned to lead. Collaboration among manufacturers, providers, payers, and regulators will be essential to harmonize incentives and accelerate adoption of care models that improve patient experience while containing system costs. In short, success will depend on the ability to translate emerging clinical and technological promise into scalable, economically viable care pathways that meet the needs of diverse patient populations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hemodialysis & Peritoneal Dialysis Market, by Treatment Type

  • 8.1. Hemodialysis
  • 8.2. Peritoneal Dialysis
    • 8.2.1. Automated Peritoneal
    • 8.2.2. Continuous Ambulatory Peritoneal

9. Hemodialysis & Peritoneal Dialysis Market, by Modality

  • 9.1. Home
    • 9.1.1. Assisted Care
    • 9.1.2. Self Care
  • 9.2. In Center

10. Hemodialysis & Peritoneal Dialysis Market, by Technology

  • 10.1. Conventional Hemodialysis
  • 10.2. Online Hemodiafiltration
    • 10.2.1. Mixed Flow
    • 10.2.2. Substitution Flow

11. Hemodialysis & Peritoneal Dialysis Market, by Product Type

  • 11.1. Concentrates Fluids
  • 11.2. Dialysis Machines
  • 11.3. Dialyzers
    • 11.3.1. High Flux
    • 11.3.2. Low Flux
  • 11.4. Monitoring Systems
  • 11.5. Tubing Sets

12. Hemodialysis & Peritoneal Dialysis Market, by Patient Type

  • 12.1. Adult
  • 12.2. Geriatric
  • 12.3. Pediatric

13. Hemodialysis & Peritoneal Dialysis Market, by End User

  • 13.1. Dialysis Centers
  • 13.2. Home Care Settings
  • 13.3. Hospitals
  • 13.4. Specialty Clinics

14. Hemodialysis & Peritoneal Dialysis Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Hemodialysis & Peritoneal Dialysis Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Hemodialysis & Peritoneal Dialysis Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Hemodialysis & Peritoneal Dialysis Market

18. China Hemodialysis & Peritoneal Dialysis Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Asahi Kasei Medical Co., Ltd.
  • 19.6. B. Braun Melsungen AG
  • 19.7. Baxter International Inc.
  • 19.8. DaVita Inc.
  • 19.9. Diaverum AB
  • 19.10. Fresenius Medical Care AG & Co. KGaA
  • 19.11. Jafron Biomedical Co., Ltd.
  • 19.12. Medica S.p.A.
  • 19.13. Medtronic plc
  • 19.14. Nipro Corporation
  • 19.15. NxStage Medical, Inc.
  • 19.16. Rockwell Medical, Inc.
  • 19.17. Toray Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 196. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 229. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 240. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)